New Strong Buy Stocks for May 26th

Zacks added five stocks to its Rank #1 (Strong Buy) list, highlighting upward revisions to current-year earnings estimates: Lifetime Brands (+19.7%), Great Elm Capital Group (+18.3%), ARKO (+11.5%), Pitney Bowes (+11.0%), and DaVita (+6.4%) over the last 60 days. The article is primarily a stock-screening and analyst-estimates update rather than a company-specific catalyst. It is modestly positive for the named equities, but the broad market impact is likely limited.

Analysis

The common thread here is not “good news,” but a narrowing of earnings dispersion: these names are seeing estimate revisions without needing a broader macro inflection. That tends to matter most in small- and mid-cap names because incremental buy flows from quant and fundamental screens can overwhelm mediocre liquidity for several weeks, creating outsized post-revision drift. The most interesting setup is LCUT/ARKO, where estimate momentum can re-rate valuation from “cheap for a reason” to “cheap with a catalyst,” especially if management simply sustains margins rather than delivering a blowout quarter.

The second-order effect is that this kind of revision cycle often forces short sellers to cover before the next print, but the durability differs by business model. DVA’s revisions are more likely to persist over months because the earnings base is operationally sticky, while PBI and GECC look more vulnerable to a mean-reversion trade once the market digests the current upgrade wave; their upside depends more on sentiment than on a durable end-demand step-up. In other words, DVA is a quality compounder re-rating candidate, while PBI/GECC are more likely to trade like event-driven momentum names.

The contrarian risk is that “strong buy” signals can cluster late in a revision cycle, especially when the estimates are moving off a depressed base. If the next earnings season shows that the upward revisions were mostly margin timing or one-time benefits, the market can quickly fade the move over 2-6 weeks. For LCUT and ARKO in particular, the market may be assuming more pricing power and demand resilience than the consumer backdrop ultimately supports, so the trade only works if volume does not deteriorate.

Net: this is a tactical long basket, not a blanket fundamental endorsement. The highest-quality expression is to own the name with the most durable earnings power and use the more cyclically fragile names as relative-value shorts if the group gets overbought.

Key Decisions for Investors

• Long DVA into the next earnings window; target a 1-2 month drift trade with tighter downside than the others because revisions are more likely to stick. Use a 5-8% trailing stop if the market starts fading healthcare defensives.
• Pair trade: long LCUT / short PBI for 4-8 weeks. LCUT has better upside asymmetry if revisions reflect genuine margin stabilization, while PBI looks more dependent on momentum than fundamental acceleration.
• If risk appetite is strong, buy a small basket long of LCUT, ARKO, and DVA, but size GECC below the others; treat GECC as a higher-beta trading name rather than a core fundamental long.